Advertisement

Indian Journal of Clinical Biochemistry

, Volume 34, Issue 1, pp 45–51 | Cite as

Anomalies in MiRNAs Machinery Gene, GEMIN-4 Variants Suggest Renal Cell Carcinoma Risk: A Small Experimental Study from North India

  • Archana Verma
  • Vibha Singh
  • Praveen Kumar Jaiswal
  • Rama D. MittalEmail author
Original Research Article
  • 19 Downloads

Abstract

GEMIN4 is a member of the GEMIN gene family which is involved in multiple pathologies including cancer. It is located on Chr17p13.3, the most notorious chromosome and a hotspot for various carcinomas. We therefore intend to find genetic variants of GEMIN4 gene associated with renal cell carcinoma risk (RCC). This study comprised 100 patients and 225 controls. Genotyping of GEMIN4 gene variants was done using Taqman® assay. The association of GEMIN4 variants and risk prediction of RCC was done by statistical analysis. Haplotype analysis was done to see the combined effect of variants on RCC. Patients carrying variant genotype, CC of GEMIN4 T/C rs7813 showed significant association whereas in case of GEMIN4 G/C rs910925 variant genotype, CC significant risk was found. GEMIN4 rs7813 T/C variant genotype, CC showed risk with smoking (p = 0.034). Our study gives a substantive support for the association between the GEMIN4 gene variants and RCC risk.

Keywords

Renal cell carcinoma (RCC) GEMIN4 gene Cancer susceptibility 

Notes

Acknowledgements

This study was funded by Department of Science and Technology (DST) [SR/SO/HS-120/2007], New Delhi. The assistance of relevant clinical information of the patients by the Urologists and Pathologist is duly acknowledged.

Compliance with Ethical Standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Chow WH, Dong LM, Devesa SS. Epidemiology and risk factors for kidney cancer. Nat Rev Urol. 2010;7:245–57.CrossRefGoogle Scholar
  2. 2.
    Esquela-Kerscher A, Slack FJ. Oncomirs—microRNAs with a role in cancer. Nat Rev Cancer. 2006;6:259–69.CrossRefGoogle Scholar
  3. 3.
    Chiosea S, Jelezcova E, Chandran U, Acquafondata M, McHale T, Sobol RW, et al. Up-regulation of dicer, a component of the microRNA machinery, in prostate adenocarcinoma. Am J Pathol. 2006;169:1812–20.CrossRefGoogle Scholar
  4. 4.
    Wu X, Lu C, Ye Y, Chang J, Yang H, Lin J, et al. Germline genetic variations in drug action pathways predict clinical outcomes in advanced lung cancer treated with platinum based chemotherapy. Pharmacogenet Genomics. 2008;18:955–65.CrossRefGoogle Scholar
  5. 5.
    Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6(11):857–66.CrossRefGoogle Scholar
  6. 6.
    Liu J, Liu J, Wei M, He Y, Liao B, Liao G, et al. Genetic variants in the microRNA machinery gene GEMIN4 are associated with risk of prostate cancer: a case-control study of the Chinese Han population. DNA Cell Biol. 2012;31(7):1296–302.CrossRefGoogle Scholar
  7. 7.
    Wan D, He M, Wang J, Qiu X, Zhou W, Luo Z, et al. Two variants of the human hepatocellular carcinoma-associated HCAP1 gene and their effect on the growth of the human liver cancer cell line Hep3B. Genes Chromosomes Cancer. 2004;39(1):48–58.CrossRefGoogle Scholar
  8. 8.
    Yang H, Dinney CP, Ye Y, Zhu Y, Grossman HB, Wu X. Evaluation of genetic variants in microRNA related genes and risk of bladder cancer. Cancer Res. 2008;68:2530–7.CrossRefGoogle Scholar
  9. 9.
    Horikawa Y, Wood CG, Yang H, Zhao H, Ye Y, Gu J, et al. Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma. Clin Cancer Res. 2008;14:7956–62.CrossRefGoogle Scholar
  10. 10.
    Lin J, Horikawa Y, Tamboli P, Clague J, Wood CG, Wu X. Genetic variations in microRNA-related genes are associated with survival and recurrence in patients with renal cell carcinoma. Carcinogenesis. 2010;31:1805–12.CrossRefGoogle Scholar
  11. 11.
    Liang D, Meyer L, Chang DW, Lin J, Pu X, Ye Y, et al. Genetic variants in Micro RNA biosynthesis pathways and binding sites modify ovarian cancer risk, survival, and treatment response. Cancer Res. 2010;70:9765–76.CrossRefGoogle Scholar
  12. 12.
    Fang X, Yin Z, Li X, Xia L, Zhou B. Polymorphisms in GEMIN4 and AGO1 genes are associated with the risk of lung cancer: a case-control study in Chinese female non-smokers. Int J Environ Res Public Health. 2016;13(10):E939.CrossRefGoogle Scholar
  13. 13.
    Ye Y, Wang KK, Gu J, Yang H, Lin J, Ajani JA, et al. Genetic variations in microRNA-related genes are novel susceptibility loci for esophageal cancer risk. Cancer Prev Res (Phila). 2008;1(6):460–9.CrossRefGoogle Scholar
  14. 14.
    Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res. 1988;16:1215.CrossRefGoogle Scholar
  15. 15.
    Lee PH, Shatkay H. F-SNP: computationally predicted functional SNPs for disease association studies. Nucl Acids Res. 2008;36:D820–4.CrossRefGoogle Scholar
  16. 16.
    Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, et al. Microarray analysis shows that some micro-RNAs downregulate large numbers of target mRNAs. Nature. 2005;433:769–73.CrossRefGoogle Scholar
  17. 17.
    Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435:834–8.CrossRefGoogle Scholar
  18. 18.
    Thomson JM, Newman M, Parker JS, Morin-Kensicki EM, Wright T, Hammond SM. Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev. 2006;20(16):2202–7.CrossRefGoogle Scholar

Copyright information

© Association of Clinical Biochemists of India 2018

Authors and Affiliations

  • Archana Verma
    • 1
  • Vibha Singh
    • 1
  • Praveen Kumar Jaiswal
    • 1
  • Rama D. Mittal
    • 1
    Email author
  1. 1.Department of Urology and Renal TransplantationSanjay Gandhi Post Graduate Institute of Medical SciencesLucknowIndia

Personalised recommendations